Access cutting-edge brain tumor treatment through this clinical trial at a research site in Philidelphia. Study-provided care at no cost to qualified participants.
Access brain tumor specialists in Philidelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain tumor treatment provided free
This is a Phase II open-label study to investigate the safety and efficacy of ACT001 in patients with DIPG and H3K27-altered HGG.
Sponsor: Nationwide Children's Hospital
Check if you qualify for this brain tumor clinical trial in Philidelphia, PA
If you're searching for brain tumor treatment options in Philidelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philidelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.